| Authors: |
Bowles JM; University of California San Diego, Division of Infectious Diseases and Global Public Health, La Jolla, CA, United States; Centre on Drug Policy Evaluation, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada., Smith LR; University of California San Diego, Division of Infectious Diseases and Global Public Health, La Jolla, CA, United States., Mittal ML; University of California San Diego, Division of Infectious Diseases and Global Public Health, La Jolla, CA, United States., Harding RW; School of Community Health Sciences, University of Nevada, Reno, United States., Copulsky E; University of California San Diego, Division of Infectious Diseases and Global Public Health, La Jolla, CA, United States., Hennessy G; University of California San Diego, Division of Infectious Diseases and Global Public Health, La Jolla, CA, United States., Dunkle A; Solace Foundation, CA, United States., Davidson PJ; University of California San Diego, Division of Infectious Diseases and Global Public Health, La Jolla, CA, United States. Electronic address: pdavidson@health.ucsd.edu., Wagner KD; School of Community Health Sciences, University of Nevada, Reno, United States. Electronic address: karlawagner@unr.edu. |
